Hybrigenics S.A. (ALHYG.PA)
Hybrigenics S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Gallargues-le-Montueux, FR. The stock last traded at $0.01, up 4.04% on the session, giving a market capitalisation of $3.9M. Its beta of 1.08 implies it has historically moved more than the broad market.
Hybrigenics SA is a biotechnology firm, along with its subsidiaries, headquartered in Gallargues-le-Montueux, France. The company specializes in pioneering biotechnological advancements, particularly within oncology, regenerative medicine, and anti-aging therapies. Additionally, Hybrigenics is actively involved in developing technical solutions that leverage adipose tissue cells and stem cells. It operates as a subsidiary of Diagnostic Medical Systems S.A.
Hybrigenics S.A. is most often compared with the following Healthcare names: